Teleflex falls after lowering 2025 revenue forecast

Shares of medical device maker Teleflex TFX.N fall 5.9% to $119.12 premarket

Co cuts revenue forecast for 2025 to $3.270 billion to $3.278 billion vs. previous forecast of $3.305 billion to $3.320 billion

Analysts were expecting a revenue of $3.32 billion - LSEG data

Co says reduction is principally the result of softer-than-expected year-end demand for intra-aortic balloon pumps and catheters in the U.S. and Asia and delays in certain purchase orders in the OEM business

Appoints Stuart Randle as interim CEO, effective immediately

Randle succeeds Liam Kelly, who departs as Chairman, President and CEO

As of last close, stock down 28.9% in the past 12 months